144 related articles for article (PubMed ID: 16292466)
1. Sex differences in clinical presentation and response in panic disorder: pooled data from sertraline treatment studies.
Clayton AH; Stewart RS; Fayyad R; Clary CM
Arch Womens Ment Health; 2006 May; 9(3):151-7. PubMed ID: 16292466
[TBL] [Abstract][Full Text] [Related]
2. Sertraline treatment of panic disorder: response in patients at risk for poor outcome.
Pollack MH; Rapaport MH; Clary CM; Mardekian J; Wolkow R
J Clin Psychiatry; 2000 Dec; 61(12):922-7. PubMed ID: 11206597
[TBL] [Abstract][Full Text] [Related]
3. Early improvement predicts endpoint remission status in sertraline and placebo treatments of panic disorder.
Pollack MH; Rapaport MH; Fayyad R; Otto MW; Nierenberg AA; Clary CM
J Psychiatr Res; 2002; 36(4):229-36. PubMed ID: 12191627
[TBL] [Abstract][Full Text] [Related]
4. Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial.
Pollack MH; Otto MW; Worthington JJ; Manfro GG; Wolkow R
Arch Gen Psychiatry; 1998 Nov; 55(11):1010-6. PubMed ID: 9819070
[TBL] [Abstract][Full Text] [Related]
5. Sertraline in the treatment of panic disorder: a double-blind multicenter trial.
Pohl RB; Wolkow RM; Clary CM
Am J Psychiatry; 1998 Sep; 155(9):1189-95. PubMed ID: 9734541
[TBL] [Abstract][Full Text] [Related]
6. Drug treatment for panic disorder with or without agoraphobia: systematic review and network meta-analysis of randomised controlled trials.
Chawla N; Anothaisintawee T; Charoenrungrueangchai K; Thaipisuttikul P; McKay GJ; Attia J; Thakkinstian A
BMJ; 2022 Jan; 376():e066084. PubMed ID: 35045991
[TBL] [Abstract][Full Text] [Related]
7. Sertraline versus paroxetine in the treatment of panic disorder: an acute, double-blind noninferiority comparison.
Bandelow B; Behnke K; Lenoir S; Hendriks GJ; Alkin T; Goebel C; Clary CM
J Clin Psychiatry; 2004 Mar; 65(3):405-13. PubMed ID: 15096081
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of sertraline in panic disorder: combined results from two fixed-dose studies.
Sheikh JI; Londborg P; Clary CM; Fayyad R
Int Clin Psychopharmacol; 2000 Nov; 15(6):335-42. PubMed ID: 11110009
[TBL] [Abstract][Full Text] [Related]
9. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
[TBL] [Abstract][Full Text] [Related]
10. Sertraline treatment of panic disorder: results of a long-term study.
Rapaport MH; Wolkow R; Rubin A; Hackett E; Pollack M; Ota KY
Acta Psychiatr Scand; 2001 Oct; 104(4):289-98. PubMed ID: 11722304
[TBL] [Abstract][Full Text] [Related]
11. Imipramine vs. sertraline in panic disorder: 24-week treatment completers.
Mavissakalian MR
Ann Clin Psychiatry; 2003; 15(3-4):171-80. PubMed ID: 14971862
[TBL] [Abstract][Full Text] [Related]
12. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder.
Ballenger JC; Wheadon DE; Steiner M; Bushnell W; Gergel IP
Am J Psychiatry; 1998 Jan; 155(1):36-42. PubMed ID: 9433336
[TBL] [Abstract][Full Text] [Related]
13. Panic disorder and response to sertraline: the effect of previous treatment with benzodiazepines.
Rapaport MH; Pollack MH; Clary CM; Mardekian J; Wolkow R
J Clin Psychopharmacol; 2001 Feb; 21(1):104-7. PubMed ID: 11199932
[TBL] [Abstract][Full Text] [Related]
14. Do antidepressants selectively suppress spontaneous (unexpected) panic attacks? A replication.
Uhlenhuth EH; Matuzas W; Warner TD; Paine S; Lydiard RB; Pollack MH
J Clin Psychopharmacol; 2000 Dec; 20(6):622-7. PubMed ID: 11106133
[TBL] [Abstract][Full Text] [Related]
15. Early coadministration of clonazepam with sertraline for panic disorder.
Goddard AW; Brouette T; Almai A; Jetty P; Woods SW; Charney D
Arch Gen Psychiatry; 2001 Jul; 58(7):681-6. PubMed ID: 11448376
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial.
Brady K; Pearlstein T; Asnis GM; Baker D; Rothbaum B; Sikes CR; Farfel GM
JAMA; 2000 Apr; 283(14):1837-44. PubMed ID: 10770145
[TBL] [Abstract][Full Text] [Related]
17. Sertraline in the treatment of panic disorder. A multi-site, double-blind, placebo-controlled, fixed-dose investigation.
Londborg PD; Wolkow R; Smith WT; DuBoff E; England D; Ferguson J; Rosenthal M; Weise C
Br J Psychiatry; 1998 Jul; 173():54-60. PubMed ID: 9850204
[TBL] [Abstract][Full Text] [Related]
18. Selective serotonin reuptake inhibitors in the treatment of panic disorder and agoraphobia.
Bakker A; van Balkom AJ; van Dyck R
Int Clin Psychopharmacol; 2000 Aug; 15 Suppl 2():S25-30. PubMed ID: 11110016
[TBL] [Abstract][Full Text] [Related]
19. Sertraline versus imipramine treatment of comorbid panic disorder and major depressive disorder.
Lepola U; Arató M; Zhu Y; Austin C
J Clin Psychiatry; 2003 Jun; 64(6):654-62. PubMed ID: 12823079
[TBL] [Abstract][Full Text] [Related]
20. Sertraline and alprazolam in the treatment of panic desorder.
Fiseković S; Loga-Zec S
Bosn J Basic Med Sci; 2005 May; 5(2):78-81. PubMed ID: 16053461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
